Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?

Front Pharmacol. 2018 Mar 22:9:245. doi: 10.3389/fphar.2018.00245. eCollection 2018.

Kulmira Nurgali^{1

2}, R Thomas Jagoe³, Raquel Abalo^{4

5

6

7}

¹ College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia.
² Department of Medicine, Western Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Regenerative Medicine and Stem Cells Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC, Australia.
³ McGill Cancer Nutrition Rehabilitation Program and the Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.
⁴ Área de Farmacología y Nutrición, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
⁵ Unidad Asociada I+D+i del Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
⁶ Unidad Asociada I+D+i del Instituto de Investigación en Ciencias de la Alimentación (CIAL), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
⁷ Grupo de Excelencia Investigadora URJC, Banco de Santander, Grupo Multidisciplinar de Investigación y Tratamiento del Dolor (i+DOL), Alcorcón, Spain.

No abstract available

Keywords: adverse effects; antineoplastic drugs; cancer treatment; chemotherapy; toxicity.

Publication types